نتائج البحث - Annette Sander

  • يعرض 1 - 4 نتائج من 4
تنقيح النتائج
  1. 1
    Monitoring of Adenovirus Infection in Pediatric Transplant Recipients by Quantitative PCR: Report of Six Cases and Review of the Literature

    Monitoring of Adenovirus Infection in Pediatric Transplant Recipients by Quantitative PCR: Report of Six Cases and Review of the Literature حسب Kathrin Seidemann, Albert Heim, Eva‐Doreen Pfister, H Köditz, Andreas Beilken, Annette Sander, Michael Melter, Karl‐Walter Sykora, Michael Sasse, Armin Wessel

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)

    Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16) حسب Ursula Creutzig, Martin Zimmermann, Jean‐Pierre Bourquin, Michael Dworzak, Christine von Neuhoff, Annette Sander, André Schrauder, Andrea Teigler‐Schlegel, Jan Starý, Selim Corbacioglu, Dirk Reinhardt

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98

    Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98 حسب Christine von Neuhoff, Dirk Reinhardt, Annette Sander, Martin Zimmermann, Jutta Bradtke, David R. Betts, Zuzana Zemanová, Jan Starý, Jean‐Pierre Bourquin, Oskar A. Haas, Michael Dworzak, Ursula Creutzig

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004

    Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004 حسب Ursula Creutzig, Martin Zimmermann, Jean‐Pierre Bourquin, Michael Dworzak, Gudrun Fleischhack, Norbert Graf, Thomas Klingebiel, Bernhard Kremens, Thomas Lehrnbecher, Christine von Neuhoff, J. Ritter, Annette Sander, André Schrauder, Arend von Stackelberg, Jan Starý, Dirk Reinhardt

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: